Hepatitis C Virus (HCV) Genotyping

Hepatitis C Virus (HCV) Genotyping Test

The Hepatitis C Virus (HCV) Genotyping Test identifies the specific genetic strain (genotype) of HCV present in an infected individual. This test is crucial for determining the most effective treatment plan since different genotypes respond differently to antiviral medications.


Why is the HCV Genotyping Test Done?

Guides Treatment Selection – Different HCV genotypes require different antiviral regimens.
Predicts Treatment Duration & Success – Some genotypes require longer treatment or combination therapies.
Assesses Risk of Chronic Infection – Some genotypes have a higher likelihood of leading to chronic hepatitis, cirrhosis, or liver cancer.
Used Before Initiating Therapy – Helps healthcare providers choose the most effective direct-acting antiviral (DAA) treatment.


How is the HCV Genotyping Test Performed?

🩸 Blood Sample Collection – A blood sample is drawn and analyzed using reverse transcription polymerase chain reaction (RT-PCR) to detect the genetic makeup of the virus.


HCV Genotypes & Their Clinical Importance

Hepatitis C has six main genotypes (1–6), with further subtypes (e.g., 1a, 1b).

Genotype Global Prevalence Treatment Considerations
Genotype 1 (1a, 1b) Most common worldwide (~46%) Requires longer treatment but responds well to DAAs.
Genotype 2 Common in Europe, Japan, China Higher cure rates with shorter treatment.
Genotype 3 Common in South Asia, Australia Higher risk of fatty liver & liver disease progression. Harder to treat.
Genotype 4 Common in the Middle East, Africa Responds well to DAAs but may require longer treatment.
Genotype 5 Common in South Africa Rare, but still treatable with DAAs.
Genotype 6 Found in Southeast Asia Similar treatment response as genotype 4.

📌 Genotype 1 is the most common worldwide and has historically been the most difficult to treat, but modern direct-acting antivirals (DAAs) have significantly improved cure rates.


Next Steps After HCV Genotyping

🔬 If HCV RNA is detected:

  • Start direct-acting antiviral (DAA) therapy based on genotype.
  • Monitor viral load to track treatment response.

🔬 If HCV RNA is NOT detected:

  • No active infection; may indicate past resolved infection or false-positive IgG test.

Additional HCV Tests

🩺 HCV Antibody (IgG) Test – Screens for past or present HCV exposure.
🧪 HCV RNA PCR Test – Confirms active infection and measures viral load.
🩸 Liver Function Tests (LFTs) – Checks for liver damage (ALT, AST, bilirubin).
📊 FibroScan or Liver Biopsy – Assesses fibrosis, cirrhosis, or liver damage severity.


Key Takeaways

HCV Genotyping is essential for choosing the most effective treatment.
Different genotypes require different antiviral medications and treatment durations.
Genotype 1 is the most common, while Genotype 3 has a higher risk of severe liver disease.
Modern DAAs have high cure rates for all genotypes, with shorter treatment durations and fewer side effects.

Original price was: ₹4,500.00.Current price is: ₹3,899.00.

[whatsapp_booking]